Table 2.
Wilson et al. [36] | Wilson et al. [34] | Wintermeyer et al. [35] | Ihle et al. [33] | Müller et al. [26] | Goisser et al. [27] | Chakravarty et al. [28] | Banks et al. [29] | Dhandapani et al. [25] | Goiburu et al. [10] | Compan et al. [30] | McClave et al. [31] | Kaufman et al. [32] | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1. Clearly stated aim | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 1 | 2 |
2. Inclusion of consecutive patients | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 0 | 0 |
3. Prospective collection of data | 2 | 2 | 2 | 2 | 2 | 2 | 0 | 2 | 2 | 2 | 2 | 2 | 0 |
4. Endpoints appropriate to aim of study | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 0 | 2 |
5. Unbiased assessment of study endpoints | 2 | 2 | 2 | 0 | 2 | 0 | 0 | 2 | 2 | 0 | 1 | 0 | 0 |
6. Follow-up period appropriate to aim of study | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
7. < 5% lost to follow-up | 2 | 1 | 2 | 2 | 0 | 2 | 2 | 1 | 1 | 1 | 0 | 2 | 1 |
8. Prospective calculation of study size | 0 | 0 | 0 | 0 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 0 | 0 |
Total | 14 | 13 | 14 | 12 | 14 | 14 | 12 | 14 | 14 | 12 | 12 | 7 | 7 |
Criteria were scored 2 (reported and adequate), 1 (reported but inadequate) or 0 (not reported), with a maximum total score of 16